Why CVS Health Stock Is Soaring Today

08.04.25 18:11 Uhr

Werte in diesem Artikel
Aktien

58,73 EUR -1,39 EUR -2,31%

Indizes

PKT PKT

15.891,7 PKT 70,3 PKT 0,44%

2.544,1 PKT -1,1 PKT -0,04%

5.282,7 PKT 7,0 PKT 0,13%

Shares of pharmacy and insurance giant CVS Health (NYSE: CVS) were soaring 8.2% higher as of 11:32 a.m. ET on Tuesday. Part of the gain undoubtedly related to the overall market's rebound following a steep sell-off on worries about the potential impact of tariffs. However, CVS Health's corporate update on Tuesday was likely a factor behind the stock's jump, too.CVS Health announced that Brian Newman will be the new CFO effective April 21, 2025. Newman is coming to CVS after serving as CFO for United Parcel Service. CVS Health's current CFO, Tom Cowhey, will move into a role as strategic advisor to CEO David Joyner on May 12, 2025. The company also named Amy Compton-Phillips as its new chief medical officer. She most recently served as chief physician executive of healthcare performance improvement company Press Ganey. Sometimes changes in the executive ranks provide a catalyst for a stock, especially when the moves involve CEOs or CFOs. In this case, though, I don't think the announcements of Newman as CFO or Compton-Phillips as chief medical officer were the key drivers of CVS Health's nice gain today. Both have solid experience and will likely be great additions to CVS Health. However, the most important news in CVS Health's update wasn't related to leadership changes, in my opinion.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

In eigener Sache

Übrigens: CVS Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf CVS Health

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CVS Health

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: MotleyFool

Nachrichten zu CVS Health Corp

Wer­bung

Analysen zu CVS Health Corp

DatumRatingAnalyst
05.06.2019CVS Health BuyStandpoint Research
15.04.2019CVS Health PerformOppenheimer & Co. Inc.
12.04.2019CVS Health Market PerformBMO Capital Markets
18.12.2018CVS Health OverweightBarclays Capital
26.10.2018CVS Health Peer PerformWolfe Research
DatumRatingAnalyst
05.06.2019CVS Health BuyStandpoint Research
12.04.2019CVS Health Market PerformBMO Capital Markets
18.12.2018CVS Health OverweightBarclays Capital
30.01.2018CVS Health Strong BuyNeedham & Company, LLC
02.01.2018CVS Health BuyNeedham & Company, LLC
DatumRatingAnalyst
15.04.2019CVS Health PerformOppenheimer & Co. Inc.
26.10.2018CVS Health Peer PerformWolfe Research
28.06.2017CVS Health HoldNeedham & Company, LLC
02.02.2017CVS Health NeutralRobert W. Baird & Co. Incorporated
22.06.2016CVS Health HoldDeutsche Bank AG
DatumRatingAnalyst
25.07.2005Update Longs Drug Stores Corp.: UnderperformBear Stearns

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CVS Health Corp nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen